ArticleBJC reports2024

Different efficacy of tyrosine kinase inhibitors by KIT and PGFRA mutations identified in circulating tumor DNA for the treatment of refractory gastrointestinal stromal tumors.

Tadayoshi Hashimoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.